Skip to main content
. 2020 Sep 15;99(3):e415–e422. doi: 10.1111/aos.14586

Table 3.

Ocular abnormalities* according to different intervention/follow‐up among neonates beyond screening criteria (Group 2).

Immediate/ timely Intervention Intervention/close or long‐term follow‐up Short‐term follow‐up
Ocular abnormalities No. of patients (% ) Ocular abnormalities No. of patients (% ) Ocular abnormalities No. of patients (% )
Congenital cataract 156 (1.28) FEVR 283 (2.32) Peripheral retinal white lesion 1321 (10.81)
Conjunctivitis 63 (0.52) ROP (like) retinopathy 241 (1.97) Retinal exudates 1236 (10.12)
Corneal Oedema 12 (0.10) Maculopathy 141 (1.15) Immature retina 1149 (9.40)
Retinitis 11 (0.09) PHPV 115 (0.94) Pigment deposition 692 (5.66)
Retinoblastoma 5 (0.04) Choroidal coloboma 97 (0.79) Depigmentation 434 (3.55)
Neonatal dacryocystitis 4 (0.03) Vitreous opacity 64 (0.52) Foveal Haemorrhage 348 (2.85)
Iris neovascularization 2 (0.02) Optic dysplasia 64 (0.52) Subconjunctival haemorrhage 265 (2.17)
Leucocoria 2 (0.02) Enlarged optic cup 51 (0.42) Retinal venous tortuosity 170 (1.39)
Exophthalmos 1 (0.01) Strabismus 18 (0.15) White without pressure 117 (0.96)
Corneal dermoid 1 (0.01) Optic coloboma 5 (0.04) Neonatal fundal jaundice 107 (8.76)
Retinal detachment 1 (0.01) Angioma of eyelid 5 (0.04) Hypopigmented fundus 35 (2.86)
Optic nerve head capillary haemangioma 4 (0.03) Albinotic fundus 15 (1.23)
Nystagmus 4 (0.03) Abnormal shape of optic disc 11 (0.09)
Persistent pupillary membranes 3 (0.02) Iris synechia 4 (0.03)
Optic atrophy 2 (0.02) MRNF 2 (0.02)
MGS 1 (0.01)
Total 258 (2.11) 1098 (8.99) 5906 (48.34)
Per cent of abnormalities accounting for total screened population (%) 0.41 1.75 9.40

FEVR = familial exudative vitreoretinopathy, MGS = morning glory syndrome, MRNF = myelinated retinal nerve fiber layer, PHPV = persistent hyperplasia of primary vitreous, ROP = retinopathy of prematurity.

*

Only retinal haemorrhage involving macula was listed in the table.

Per cent of abnormalities accounting for total ocular abnormalities.